Skip to main content

MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

01 Nov 2026 Evaluate
The sales slipped to Rs. 232.95 millions for the September 2026 quarter as against Rs. 303.15 millions during the year-ago period.The Company to register a -67.02%  fall in the net profit for the quarter ended September 2026.The Operating Profit of the company witnessed a decrease to 53.42 millions from 103.09 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 232.95 303.15 -23.16 376.55 549.83 -31.52 1092.86 1085.96 0.64
Other Income 14.06 6.90 103.77 23.45 13.52 73.45 30.30 37.30 -18.77
PBIDT 53.42 103.09 -48.18 96.34 182.68 -47.26 380.50 429.42 -11.39
Interest 5.75 10.10 -43.07 8.94 19.50 -54.15 35.62 20.77 71.50
PBDT 47.67 92.99 -48.74 87.40 163.18 -46.44 344.88 408.65 -15.61
Depreciation 25.03 25.87 -3.25 49.44 50.07 -1.26 104.73 95.67 9.47
PBT 22.64 67.12 -66.27 37.96 113.11 -66.44 240.15 312.98 -23.27
TAX 6.29 17.55 -64.16 10.40 29.04 -64.19 62.42 81.99 -23.87
Deferred Tax 0.58 2.17 -73.27 1.23 3.47 -64.55 5.33 -0.45 -1284.44
PAT 16.35 49.57 -67.02 27.56 84.07 -67.22 177.73 230.99 -23.06
Equity 128.38 128.38 0.00 128.38 128.38 0.00 128.38 128.38 0.00
PBIDTM(%) 22.93 34.01 -32.57 25.58 33.22 -22.99 34.82 39.54 -11.95
Peers
Company Name CMP
Sun Pharma. Inds. 1776.00
Dr. Reddys Labs. 1372.00
Cipla 1400.10
Lupin 2015.00
Zydus Lifesciences 1190.00
View more..